Calyxt Inc (NASDAQ:CLXT) was the recipient of a large increase in short interest in November. As of November 29th, there was short interest totalling 543,200 shares, an increase of 19.2% from the November 14th total of 455,600 shares. Currently, 5.4% of the company’s shares are sold short. Based on an average daily volume of 144,000 shares, the days-to-cover ratio is currently 3.8 days.

A number of large investors have recently modified their holdings of the business. River & Mercantile Asset Management LLP acquired a new position in shares of Calyxt during the second quarter valued at $146,000. Swiss National Bank acquired a new position in shares of Calyxt during the second quarter valued at $228,000. Charles Schwab Investment Management Inc. increased its holdings in shares of Calyxt by 56.5% during the second quarter. Charles Schwab Investment Management Inc. now owns 21,848 shares of the company’s stock valued at $273,000 after purchasing an additional 7,887 shares during the period. Essex Investment Management Co. LLC increased its holdings in shares of Calyxt by 91.4% during the third quarter. Essex Investment Management Co. LLC now owns 22,436 shares of the company’s stock valued at $127,000 after purchasing an additional 10,716 shares during the period. Finally, Wells Fargo & Company MN increased its holdings in shares of Calyxt by 52.3% during the second quarter. Wells Fargo & Company MN now owns 24,679 shares of the company’s stock valued at $309,000 after purchasing an additional 8,475 shares during the period. 27.21% of the stock is owned by institutional investors.

NASDAQ:CLXT traded up $0.07 during trading hours on Friday, hitting $7.16. The stock had a trading volume of 404,826 shares, compared to its average volume of 287,325. The company has a current ratio of 12.38, a quick ratio of 11.97 and a debt-to-equity ratio of 0.25. Calyxt has a 1-year low of $3.55 and a 1-year high of $19.30. The business has a 50 day simple moving average of $4.53 and a two-hundred day simple moving average of $7.67. The company has a market cap of $235.92 million, a PE ratio of -7.87 and a beta of 2.26.

Calyxt (NASDAQ:CLXT) last issued its quarterly earnings data on Wednesday, November 6th. The company reported ($0.32) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.31) by ($0.01). Calyxt had a negative net margin of 1,016.27% and a negative return on equity of 43.09%. The firm had revenue of $2.97 million during the quarter. Research analysts expect that Calyxt will post -1.18 EPS for the current fiscal year.

A number of analysts recently issued reports on CLXT shares. Zacks Investment Research downgraded shares of Calyxt from a “hold” rating to a “sell” rating in a research report on Monday, December 2nd. BMO Capital Markets dropped their target price on shares of Calyxt to $15.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Finally, BidaskClub raised shares of Calyxt from a “strong sell” rating to a “sell” rating in a research report on Thursday, September 12th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $16.50.

About Calyxt

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes.

Featured Article: NASDAQ Stock Market Explained

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.